Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
2
×
biotech
2
×
boston blog main
boston top stories
eli lilly
europe blog main
europe top stories
life sciences
national blog main
national top stories
alkermes
allergan
allergan aesthetics
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
biontech
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
buprenorphine
cancer
cancer drugs
cariprazine
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
clinical trials
covid-19
cullinan oncology
cystic fibrosis
daniel o'day
deals
detroit blog main
detroit top stories
diabetic macular edema
diagnostics
dogma therapeutics
What
drug
2
×
acquisitions
alkermes
antipsychotic
benefits
biggest
bio
build
buy
caveats
ceo
commonly
company’s
daniel
debut
designed
dyne’s
effect
favor
fda
gain
gilead
medicine
microbiome
moves
offer
openly
o’day
panel
pipeline
prescribed
psyche
roundup
sciences
scores
seagen
spoken
treatment
vote
way
Language
unset
2
×
Current search:
abbvie
×
biotech
×
unset
×
drug
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
